secwatch.observer — SEC 8-K summary
======================================

Issuer:     Electromed, Inc. (ELMD)
CIK:        0001488917
Form:       8-K
Filed at:   2021-11-09T23:59:59+00:00
Accession:  0000897101-21-000913
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Electromed Q1 FY2022 revenue hits record $10.0M, up 25% YoY; EPS $0.05 vs $0.06
-------------------------------------------------------------------------------

- Net revenue $10.0M, record quarterly; home care up 24.4% to $9.3M, institutional up 61.5% to $449K.
- Net income $439K ($0.05 diluted EPS) vs $535K ($0.06) prior year; operating income $538K vs $663K.
- Gross margin 77.0% vs 76.8%; SG&A rose to 67.9% of revenue due to strategic investments and shareholder activism costs.
- Cash $11.0M, no debt; field sales employees 51 (41 direct reps), with record annualized home care revenue per rep of $955K.
- Next-gen airway clearance device expected to launch in first half of FY2023 after FDA 510(k) clearance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1488917/000089710121000913/0000897101-21-000913-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1488917/000089710121000913/elmd211375_8k.htm
  HTML page:      https://secwatch.observer/filing/0000897101-21-000913

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer